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Clinics 
Age and sex 
64 years old male patient. 
Previous history 
No preleukemia, previous malignancy Chronic 
lymphocytic leukaemia/Small lymphocytic lymphoma 
(CLL/SLL) diagnosed 19 months earlier, in first relapse 
after 4 cycles of RFC (Fludarabine, cyclophosphamide 
and Rituximab), no inborn condition of note. 
Organomegaly 
No hepatomegaly, no splenomegaly, enlarged lymph 
nodes (diffuse lymphadenopathy),  no central nervous 
system involvement  
Blood 
WBC : 1.5 X 109/l 
HB : 10.3g/dl 
Platelets : 52 X 109/l 
Bone marrow : Aspirate and immunophenotype study: 
69.8% lymphoid cells, CD19+, CD5++, CD11c+, 







Small lymphocytic lymphoma/chronic lymphocytic 
leukemia (SLL/CLL) 
Rearranged Ig Tcr 
Not done 
Pathology 
Lymph node biopsy showed SLL/CLL, CD20, CD23, 
CD5, CD43 and BCL2 positive; CD10 and Cyclin D1 




Chronic lymphocytic leukaemia/Small lymphocytic 
lymphoma (CLL/SLL) with high Ki-67 index. 
Survival 
Date of diagnosis: 03-2010 
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Complete remission : no  
Treatment related death : + 
Status : Dead; Last follow up 07-2010. 
Survival: 4 months 
Karyotype 
Sample: bone marrow cells. 





(using ISCN): 44,XY, t(1;6)(p35;p25), der(4)(q21), -9, 
add(17)(p13), -21, +mar[6]/46,XY[14] 
Karyotype at Relapse: not done 
Other molecular cytogenetics technics: 
Fish using deletion probe XLP53 (MetaSystems) 
confirms 17p13/P53 locus deletion nuc 
ish(D17Z1x2,p53x1)[76/100] 
Other Molecular Studies 
Technics: not done 
 
Partial karyotypes, G- bands, showing the t(1;6)(p35;q21), del(4)(q21), and add(17)(p13). 
 
Fish interphase study using probes D17Z1 (green) and p53 (orange) showing 2 green signals and 1 orange signal, confirming p53 
deletion. 
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Ki-67 immunostaining in lymph node at time of t(1;6) detection. 
 
Comments 
Until now, 16 patients with CLL and t(1;6)(p35;p25) 
were described. 8 of these patients were described by 
Michaux et al. in 2005, showing that this rearrangement 
was associated with bad prognosis: unmutated B-CLL 
and evolution to diffuse large B-cell Lymphoma 
(DLBCL). Our group also described in 2007 a case of 
atypical CLL with evolution to aggressive B-cell 
Lymphoma. In the case reported herein, clinical and 
pathological evolution was associated with the 
detection of t(1;6) as part of complex karyotype 
including deletion of p53. Although no transformation 
to DLBCL was seen, increase in proliferation rate in 
lymph node biopsy (Ki-67 increase from less than10 to 
25%) was detected, associated with bad prognosis and 
short survival. 
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